Immunophotonics is an early stage biotechnology company engaged in the development of a proprietary novel drug product for use in an in situ autologous cancer vaccine (inCVAX) for the treatment of metastatic solid tumor cancers.

from http://www.immunophotonics.com/

Publications show all

ImmunoPhotonics has published 5 articles.

Patents show all

12Applications7Issued

SEC Filings show all

D3

Contact Information

1601 South Providence Road, Suite 113
Columbia, MO 65211
United States

636-675-6161

    Overview

    Total FundingEmployeesLast Funding DateStatus
    $4,250,1231-102015-01-26Operating

    Crunchbase Investment Rounds

    DateAmountRoundValuationLead InvestorOther Investors
    2014-07-31VentureBilliken Angels Network
    2011-05-27$100,123Venture
    2010-05-12$550,000Venture
    2015-01-26$1,800,000VentureCultivation CapitalMissouri Technology Corporation, St. Louis Arch Angels, BioGenerator, Billiken Angels Network, iSELECT FUND
    2014-09-03$1,800,000VentureBioGenerator, Cultivation CapitaliSELECT FUND